Glenmark Generics had recently announced new drug application (NDA) for its drug Oxycodone Hydrochloride capsules and liquid solutions, which was submitted by their partner Lehigh Valley Technologies (LVT) to the US Food and Drug Administration (FDA).
Interested in Monitoring? Call 877-596-2224
Current Customers Call 877-296-6465
Patients & Other Questions Call 877-643-6179